| Mohammad Ali Esmadi, MD | |
|
1900 Kildaire Farm Rd, Cary, NC 27518-6616 | |
| (919) 235-6440 | |
| Not Available |
| Full Name | Mohammad Ali Esmadi |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 15 Years |
| Location | 1900 Kildaire Farm Rd, Cary, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215211032 | NPI | - | NPPES |
| 470687317-16 | Medicaid | NE | |
| 100263273-00 | Medicaid | NE | |
| 1215211032 | Medicaid | IA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Cary Hospital | Cary, NC | Hospital |
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wakemed Specialists Group Llc | 2466788377 | 690 |
News Archive
The Board of Directors of Precise Biometrics has resolved, subject to approval of the AGM on April 27, to undertake an issue with preferential rights for Precise Biometrics' shareholders that will raise a maximum of SEK 54 million before deduction of issue related costs.
A company in the U.S. says it has a blood test in the pipeline which is able to detect the early signs of Parkinson's and Alzheimer's disease.
There's a multi-billion-dollar industry devoted to products that fight signs of aging, but moisturizers only go skin deep. Aging occurs deeper - at a cellular level - and scientists have found that eating less can slow this cellular process.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.
› Verified 4 days ago
| Entity Name | Raleigh Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104962315 PECOS PAC ID: 6800874322 Enrollment ID: O20040712000418 |
News Archive
The Board of Directors of Precise Biometrics has resolved, subject to approval of the AGM on April 27, to undertake an issue with preferential rights for Precise Biometrics' shareholders that will raise a maximum of SEK 54 million before deduction of issue related costs.
A company in the U.S. says it has a blood test in the pipeline which is able to detect the early signs of Parkinson's and Alzheimer's disease.
There's a multi-billion-dollar industry devoted to products that fight signs of aging, but moisturizers only go skin deep. Aging occurs deeper - at a cellular level - and scientists have found that eating less can slow this cellular process.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.
› Verified 4 days ago
| Entity Name | Wakemed Specialists Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588227839 PECOS PAC ID: 2466788377 Enrollment ID: O20190731000815 |
News Archive
The Board of Directors of Precise Biometrics has resolved, subject to approval of the AGM on April 27, to undertake an issue with preferential rights for Precise Biometrics' shareholders that will raise a maximum of SEK 54 million before deduction of issue related costs.
A company in the U.S. says it has a blood test in the pipeline which is able to detect the early signs of Parkinson's and Alzheimer's disease.
There's a multi-billion-dollar industry devoted to products that fight signs of aging, but moisturizers only go skin deep. Aging occurs deeper - at a cellular level - and scientists have found that eating less can slow this cellular process.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Ali Esmadi, MD 1900 Kildaire Farm Rd, Cary, NC 27518-6616 Ph: (919) 235-6440 | Mohammad Ali Esmadi, MD 1900 Kildaire Farm Rd, Cary, NC 27518-6616 Ph: (919) 235-6440 |
News Archive
The Board of Directors of Precise Biometrics has resolved, subject to approval of the AGM on April 27, to undertake an issue with preferential rights for Precise Biometrics' shareholders that will raise a maximum of SEK 54 million before deduction of issue related costs.
A company in the U.S. says it has a blood test in the pipeline which is able to detect the early signs of Parkinson's and Alzheimer's disease.
There's a multi-billion-dollar industry devoted to products that fight signs of aging, but moisturizers only go skin deep. Aging occurs deeper - at a cellular level - and scientists have found that eating less can slow this cellular process.
Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.
Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.
› Verified 4 days ago
Mrs. Novlet Jarrett Davis, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 875 Walnut St # 275-9, Cary, NC 27511 Phone: 919-749-6288 Fax: 919-443-1268 | |
Dr. Shilpa Bhardwaj, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6715 Mccrimmon Pkwy Ste 300, Cary, NC 27519 Phone: 919-481-4997 Fax: 919-388-3271 | |
Mohammad Saeed Anwar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 210 New Edition Ct, Cary, NC 27511 Phone: 919-568-1600 Fax: 919-650-3039 | |
Dr. Scott Carter Bilbro, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 530 New Waverly Pl, Suite 200, Cary, NC 27511 Phone: 919-859-5955 Fax: 919-859-5659 | |
Harishchandra Mahaseth, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 105 Kilmayne Dr Ste A, Cary, NC 27511 Phone: 919-467-2253 | |
Sheila A. Shine, N.P. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 300 Ashville Ave, Ste 310, Cary, NC 27518 Phone: 919-233-8585 Fax: 919-233-8566 | |
Dr. Byron Kenneth Cole, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 401 Hickorywood Blvd., Cary, NC 27519 Phone: 919-468-9960 |